GPT Healthcare Ltd (GPTHEALTH) - Net Assets
Based on the latest financial reports, GPT Healthcare Ltd (GPTHEALTH) has net assets worth Rs2.69 Billion INR (≈ $29.14 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Rs4.65 Billion ≈ $50.26 Million USD) and total liabilities (Rs1.95 Billion ≈ $21.12 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore GPT Healthcare Ltd asset portfolio for the complete picture of this company's asset base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | Rs2.69 Billion |
| % of Total Assets | 57.97% |
| Annual Growth Rate | 13.08% |
| 5-Year Change | 70.33% |
| 10-Year Change | N/A |
| Growth Volatility | 8.31 |
GPT Healthcare Ltd - Net Assets Trend (2017–2025)
This chart illustrates how GPT Healthcare Ltd's net assets have evolved over time, based on quarterly financial data. Check GPT Healthcare Ltd (GPTHEALTH) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Annual Net Assets for GPT Healthcare Ltd (2017–2025)
The table below shows the annual net assets of GPT Healthcare Ltd from 2017 to 2025. For live valuation and market cap data, see GPTHEALTH company net worth.
| Year | Net Assets | Change |
|---|---|---|
| 2025-09-30 | Rs2.69 Billion ≈ $29.14 Million |
+8.71% |
| 2024-09-30 | Rs2.48 Billion ≈ $26.80 Million |
+13.44% |
| 2023-09-30 | Rs2.18 Billion ≈ $23.63 Million |
+32.13% |
| 2022-09-30 | Rs1.65 Billion ≈ $17.88 Million |
+4.54% |
| 2021-09-30 | Rs1.58 Billion ≈ $17.11 Million |
+18.13% |
| 2020-09-30 | Rs1.34 Billion ≈ $14.48 Million |
+5.58% |
| 2019-09-30 | Rs1.27 Billion ≈ $13.72 Million |
+9.50% |
| 2018-09-30 | Rs1.16 Billion ≈ $12.53 Million |
+14.95% |
| 2017-09-30 | Rs1.01 Billion ≈ $10.90 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to GPT Healthcare Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 2037.6% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (September 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | Rs1.10 Billion | 40.95% |
| Common Stock | Rs820.55 Million | 30.46% |
| Other Comprehensive Income | Rs1.87 Billion | 69.54% |
| Total Equity | Rs2.69 Billion | 100.00% |
GPT Healthcare Ltd Competitors by Market Cap
The table below lists competitors of GPT Healthcare Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Airtel Africa Plc
LSE:AAF
|
$145.52 Million |
|
Combined Motor Holdings Limited
JSE:CMH
|
$145.55 Million |
|
TerrAscend Corp
F:TED
|
$145.67 Million |
|
Elme Communities
NYSE:ELME
|
$145.73 Million |
|
Trada Maritime Tbk
JK:TRAM
|
$145.45 Million |
|
Rotem Shani Entrepreneurship and Investments Ltd
TA:RTSN
|
$145.44 Million |
|
Zhejiang Zone King Environmental Sci&Tech Co Ltd
SHG:688701
|
$145.40 Million |
|
Mersana Therapeutics Inc
NASDAQ:MRSN
|
$145.36 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in GPT Healthcare Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 2,478,506,000 to 2,694,280,000, a change of 215,774,000 (8.7%).
- Net income of 422,205,000 contributed positively to equity growth.
- Dividend payments of 205,137,000 reduced retained earnings.
- Other comprehensive income increased equity by 1,861,485,001.
- Other factors decreased equity by 1,862,779,001.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | Rs422.20 Million | +15.67% |
| Dividends Paid | Rs205.14 Million | -7.61% |
| Other Comprehensive Income | Rs1.86 Billion | +69.09% |
| Other Changes | Rs-1.86 Billion | -69.14% |
| Total Change | Rs- | 8.71% |
Book Value vs Market Value Analysis
This analysis compares GPT Healthcare Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 4.99x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has increased from 4.33x to 4.99x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-09-30 | Rs37.83 | Rs163.94 | x |
| 2018-09-30 | Rs14.49 | Rs163.94 | x |
| 2019-09-30 | Rs15.87 | Rs163.94 | x |
| 2020-09-30 | Rs16.32 | Rs163.94 | x |
| 2021-09-30 | Rs19.28 | Rs163.94 | x |
| 2022-09-30 | Rs20.15 | Rs163.94 | x |
| 2023-09-30 | Rs27.26 | Rs163.94 | x |
| 2024-09-30 | Rs30.19 | Rs163.94 | x |
| 2025-09-30 | Rs32.86 | Rs163.94 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently GPT Healthcare Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 15.67%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 8.93%
- • Asset Turnover: 1.02x
- • Equity Multiplier: 1.72x
- Recent ROE (15.67%) is below the historical average (16.94%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2017 | 7.52% | 5.18% | 0.64x | 2.28x | Rs-24.94 Million |
| 2018 | 12.91% | 8.70% | 0.67x | 2.22x | Rs33.70 Million |
| 2019 | 8.64% | 5.17% | 0.69x | 2.43x | Rs-17.26 Million |
| 2020 | 15.75% | 8.71% | 0.76x | 2.37x | Rs77.03 Million |
| 2021 | 26.34% | 12.37% | 1.04x | 2.04x | Rs258.45 Million |
| 2022 | 23.59% | 10.80% | 1.10x | 1.98x | Rs224.71 Million |
| 2023 | 21.86% | 11.96% | 1.16x | 1.58x | Rs259.20 Million |
| 2024 | 20.14% | 12.01% | 1.08x | 1.55x | Rs251.37 Million |
| 2025 | 15.67% | 8.93% | 1.02x | 1.72x | Rs152.78 Million |
Industry Comparison
This section compares GPT Healthcare Ltd's net assets metrics with peer companies in the Medical Care Facilities industry.
Industry Context
- Industry: Medical Care Facilities
- Average net assets among peers: $26,816,380,444
- Average return on equity (ROE) among peers: 5.01%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| GPT Healthcare Ltd (GPTHEALTH) | Rs2.69 Billion | 7.52% | 0.72x | $145.48 Million |
| Apollo Hospitals Enterprise Limited (APOLLOHOSP) | $65.31 Billion | 12.54% | 1.21x | $13.71 Billion |
| Aster DM Healthcare Limited (ASTERDM) | $11.42 Billion | 8.03% | 0.87x | $4.56 Billion |
| Healthcare Global Enterprises Limited (HCG) | $2.96 Billion | -3.55% | 1.40x | $1.08 Billion |
| Jupiter Life Line Hospitals Limited (JLHL) | $13.56 Billion | 14.24% | 0.40x | $226.19 Million |
| Krishna Institute of Medical Sciences Limited (KIMS) | $5.67 Billion | -8.43% | 0.98x | $3.55 Billion |
| Lotus Eye Hospital and Institute Limited (LOTUSEYE) | $527.27 Million | -0.45% | 0.07x | $26.42 Million |
| Max Healthcare Institute Limited (MAXHEALTH) | $93.81 Billion | 11.47% | 0.62x | $11.58 Billion |
| Max India Limited (MAXIND) | $14.21 Billion | -2.98% | 0.65x | $99.20 Million |
| Global Health Limited (MEDANTA) | $33.88 Billion | 14.21% | 0.41x | $4.20 Billion |
About GPT Healthcare Ltd
GPT Healthcare Limited owns and operates a chain of multispecialty hospitals under the ILS Hospitals brand name in India. The company offers healthcare services, including internal medicine and diabetology; nephrology, such as renal transplants; laparoscopic and general surgery; gynecology and obstetrics; critical care; gastroenterology; orthopedics and joint replacement; interventional cardiolog… Read more